【発明の名称】レトロウイルス性プロテアーゼ阻止剤

Japanese Patent JPH03504247

A

A retroviral protease inhibiting compound of the formula: or a pharmaceutically acceptable salt, prodrug or ester thereof.

Kemp, Dale Jei
Platztoner, Jakob Jei
Novetsk, Daniel Davrill
Boyd, Stephen A
Baker, William Earl
Ericsson
Huang, Antony Kay El
Crawley, Stephen Earl

JP50603389A

September 19, 1991

May 12, 1989

Click for automatic bibliography generation  

Abbot Laboratories

A61K31/275; A61K31/335; A61K31/34; A61K31/341; A61K31/357; A61K31/365; A61K31/38; A61K31/381; A61K31/40; A61K31/405; A61K31/42; A61K31/421; A61K31/4245; A61K31/425; A61K31/426; A61K31/428; A61K31/44; A61K31/535; A61K31/5375; A61K31/5377; A61K31/54; A61K38/55; A61P31/12; A61P43/00; C07C233/36; C07C233/47; A61K31/16; C07C235/10; C07C235/12; C07C237/10; C07C237/12; C07C237/22; C07C271/22; C07C317/44; C07C323/60; C07D207/12; C07D207/337; C07D213/81; C07D231/12; C07D233/32; C07D233/36; C07D233/64; C07D239/04; C07D239/10; C07D257/04; C07D263/06; C07D263/16; C07D263/20; C07D263/22; C07D263/24; C07D263/26; C07D265/06; C07D265/10; C07D271/10; C07D273/00; C07D277/28; C07D277/64; C07D277/66; C07D295/20; C07D295/205; C07D295/215; C07D307/14; C07D307/28; C07D307/58; C07D307/68; C07D309/04; C07D309/20; C07D317/34; C07D317/36; C07D333/38; C07D407/04; C07D413/04; C07D413/06; C07K5/06; C07K5/065; C07K5/103; C07K5/107; C07K7/02; A61K38/00; (IPC1-7): A61K31/16; A61K31/275; A61K31/335; A61K31/34; A61K31/365; A61K31/38; A61K31/40; A61K31/405; A61K31/42; A61K31/425; A61K31/44; A61K31/535; A61K31/54; A61K37/64; C07; C07C233/36; C07C233/47; C07C235/10; C07C235/12; C07C237/10; C07C237/12; C07C237/22; C07C317/44; C07C323/60; C07D207/12; C07D207/337; C07D213/81

JPS59227851A

1984-12-21

Yoshio Kawaguchi (4 outside)

Previous Patent: JPH03504246

Next Patent: HIGH-DEGREE TREATMENT METHOD FOR FLUORINE COMPOUND- CONTAINING LIQUID